A Single-arm, Exploratory Clinical Study to Evaluate the Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined with Anlotinib, Albumin-bound Paclitaxel, and Carboplatin as Neoadjuvant Therapy in Triple-negative Breast Cancer

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: e90642a41ff282babd86972f6bc67146533f47ad
First added on: Sep 12, 2026